Advanced Health Intelligence Late Thursday Announced Exclusive License Deal with Changlin Network Technology Ltd
Portfolio Pulse from Charles Gross
Advanced Health Intelligence Ltd (AHI) has signed an exclusive, perpetual license agreement with Shanghai-based Changlin Network Technology Ltd. The deal includes an upfront payment of $10 million to AHI, an annual license fee of $5 million, and a 25% revenue share of gross sales. Changlin, planning an IPO in 2024, will initially issue a 50% holding to AHI, which will later be reduced to 25-20%. The deal is contingent on Changlin securing financing and SAFE approval in China.
August 04, 2023 | 2:54 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The deal with Changlin could significantly boost AHI's revenues with the upfront payment, annual license fee, and revenue share. However, the deal's completion is contingent on Changlin securing financing and SAFE approval.
The deal could significantly increase AHI's revenues, which would likely boost its stock price. However, the deal's completion is not guaranteed as it depends on Changlin securing financing and SAFE approval. If these conditions are not met, the deal will not proceed, which could negatively impact AHI's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
The deal between AHI and Changlin, a Shanghai-based company, could indirectly impact FXI, an ETF that tracks Chinese large-cap stocks, especially if Changlin goes public in 2024.
While FXI is not directly involved in the deal, it could be indirectly impacted due to its exposure to Chinese large-cap stocks. If Changlin goes public in 2024, it could potentially become part of the ETF's holdings, which could impact its performance.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 50